Adipocyte‐Derived Palmitic Acid Promotes Breast Cancer Malignancy via ZDHHC15‐Mediated S‐Palmitoylation of PPARγ
Geon Ho Moon, Min Young Lee, Jiwon Koh, Ki Yong Hong, Junji Fukuda, Sung Joon Kim, Yang‐Sook Chun · 2026
Read Adipocyte‐Derived Palmitic Acid Promotes Breast Cancer Malignancy via ZDHHC15‐Mediated S‐Palmitoylation of PPARγ by Geon Ho Moon, Min Young Lee, Jiwon Koh, Ki Yong Hong, Junji Fukuda, Sung Joon Kim, Yang‐Sook Chun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13424263.txt.
Description
Moon and co-authors trace a fat-driven sabotage in this 2026 study of breast cancer, where the tissue around tumors is rich in fat cells. A protein called PPAR gamma normally restrains breast cancer growth, and a drug that activates it, rosiglitazone, has disappointed in the clinic. The team asked whether fat from neighboring adipocytes disables the guardian.
Palmitic acid released by fat cells triggered an enzyme, ZDHHC15. The enzyme attaches a palmitate tag to PPAR gamma. The modification, called S-palmitoylation, marks the protein for destruction by the cell's recycling machinery. In three-dimensional tumor spheroids fed by fat-cell media, the tagging promoted malignancy and blunted rosiglitazone. A tagging blocker, 2-bromopalmitate, saved the protein, suppressed the malignant behavior, and worked strongly with rosiglitazone, marking the tagging step as a drug target.
Catalog record
| CREATOR | Geon Ho Moon, Min Young Lee, Jiwon Koh, Ki Yong Hong, Junji Fukuda, Sung Joon Kim, Yang‐Sook Chun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |